Literature DB >> 28067403

MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy.

Hamed Mirzaei1, Fatemeh Momeni2, Leila Saadatpour3, Amirhossein Sahebkar4, Mohammad Goodarzi5, Aria Masoudifar6, Shirin Kouhpayeh7, Hossein Salehi8, Hamid Reza Mirzaei9, Mahmoud Reza Jaafari10.   

Abstract

Stroke is a life-threatening disease that accounts for a considerable burden of mortality in both developing and developed world. Identification of specific biomarkers for stroke and its outcomes can greatly contribute to improved care of patients. MicroRNAs (miRNAs) are known as novel biomarkers that could be used as diagnostic, prognostic, and therapeutic biomarkers. Various studies have shown that miRNAs have key roles in the pathogenesis of stroke, and its complications and outcomes. In addition, there is evidence showing that mesenchaymal stromal cell-derived exosomes containing miRNAs can be used for monitoring and treatment of various diseases such as stroke. Here, we summarized various aspects of miRNA applications in different stages of stroke.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarker; exosome; meseanchaymal stromal cell; microRNA; stroke

Mesh:

Substances:

Year:  2017        PMID: 28067403     DOI: 10.1002/jcp.25787

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  56 in total

1.  A SERS-based lateral flow assay for the stroke biomarker S100-β.

Authors:  Ying Wang; Yajun Hou; Hanxia Li; Mingfeng Yang; Peng Zhao; Baoliang Sun
Journal:  Mikrochim Acta       Date:  2019-07-18       Impact factor: 5.833

Review 2.  The Story of Nanoparticles in Differentiation of Stem Cells into Neural Cells.

Authors:  Vajihe Asgari; Amir Landarani-Isfahani; Hossein Salehi; Noushin Amirpour; Batool Hashemibeni; Saghar Rezaei; Hamid Bahramian
Journal:  Neurochem Res       Date:  2019-11-12       Impact factor: 3.996

3.  MiR-27a-3p downregulation contributes to the development of occlusive bronchiolitis.

Authors:  Ming Dong; Xin Wang; Yong Guan; Tong Li
Journal:  Cell Stress Chaperones       Date:  2019-08-27       Impact factor: 3.667

4.  Hypoxia/reoxygenation-induced upregulation of miRNA-542-5p aggravated cardiomyocyte injury by repressing autophagy.

Authors:  Fei Wang; Xin Min; Shan-You Hu; Da-Li You; Ting-Ting Jiang; Li Wang; Xiao Wu
Journal:  Hum Cell       Date:  2021-01-04       Impact factor: 4.174

5.  Noncoding RNAs and Stroke.

Authors:  Xuejing Zhang; Milton H Hamblin; Ke-Jie Yin
Journal:  Neuroscientist       Date:  2018-04-11       Impact factor: 7.519

Review 6.  RNA expression studies in stroke: what can they tell us about stroke mechanism?

Authors:  Sarina Falcione; Joseph Kamtchum-Tatuene; Gina Sykes; Glen C Jickling
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

7.  Cerebral endothelial cell-derived small extracellular vesicles enhance neurovascular function and neurological recovery in rat acute ischemic stroke models of mechanical thrombectomy and embolic stroke treatment with tPA.

Authors:  Chao Li; Chunyang Wang; Yi Zhang; Owais K Alsrouji; Alex B Chebl; Guangliang Ding; Quan Jiang; Stephan A Mayer; Mei Lu; Max K Kole; Horia L Marin; Li Zhang; Michael Chopp; Zheng Gang Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2021-02-08       Impact factor: 6.200

Review 8.  MicroRNAs as regulators of brain function and targets for treatment of epilepsy.

Authors:  Gary P Brennan; David C Henshall
Journal:  Nat Rev Neurol       Date:  2020-06-16       Impact factor: 42.937

9.  Association of MicroRNA Biogenesis Genes Polymorphisms with Risk of Large Artery Atherosclerosis Stroke.

Authors:  Mengmeng Wang; Jinyu Gu; Chong Shen; Wuzhuang Tang; Xiaoru Xing; Zhizhong Zhang; Xinfeng Liu
Journal:  Cell Mol Neurobiol       Date:  2021-02-23       Impact factor: 5.046

10.  miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.

Authors:  Yan Feng; Yan Li; Ying Zhang; Bo-Hao Zhang; Hui Zhao; Xin Zhao; Fu-Dong Shi; Wei-Na Jin; Xiao-An Zhang
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.